OPGN (OpGen Corporation) Kacepetan wutah bathi saben saham ing taun lumaku

Simbol resmi perusahaan OpGen, Inc. (OPGN)

OpGen, Inc. (OPGN) has developed an infection control system that integrates molecular diagnostics with resistance data. Annual EPS growth peaked before declining, and the 0.00 level now serves as a critical benchmark. Management is currently facing a profound crisis of confidence due to a failed strategy, while the implementation of digital microbiology platforms in clinics is yielding moderate results as the company awaits new licensing contracts.

opgen.com (OPGN): Wutah bathi resik saben saham ing taun iki saka 04.07.2022 nganti 31.08.2024

Rincian analitis lan laporan data perusahaan OpGen, Inc. (OPGN)

- rega saiki lan proyeksi nilai saham:
Bagan kutipan OpGen Inc|OPGN - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar OpGen Corporation|OPGN - Nilai Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi saben Saham OpGen|OPGN - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku opgen.com|OPGN - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Koefisien Total Utang marang Modal OpGen, Inc.|OPGN - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal opgen.com|OPGN - Utang perusahaan|Rasio utang marang nilai buku OpGen Corporation|OPGN - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak OpGen|Likuiditas darurat opgen.com
- data bathi resik lan rasio valuasi:
OPGN - Bathi resik perusahaan|Bathi forward OpGen, Inc.|OPGN - Pangali P/E|Pangali forward rega marang bathi OpGen Corporation|OPGN - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan OpGen Corporation|OPGN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan OpGen|OPGN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan opgen.com|OPGN - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep OpGen, Inc.
Analisis dhasar perusahaan:OpGen Inc
Produk seri OpGen Corp

This indicator measures the year-over-year earnings per share (EPS) dynamics for OpGen, Inc. (OPGN), reflecting the efficiency of net income generation relative to the cost of capital. By analyzing the EPS comparison with the previous year, an investor assesses how the implementation of diagnostic systems in hospitals converts into actual financial results. Steady growth in this metric confirms the scalability of the business model and the company's resilience to operating expenses.

Pesaing utama

Dinamika bathi saben saham ing taun lumaku SMMT (Summit Therapeutics plc)|MRNA (Moderna Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku SutroVax PCVX|Wutah bathi ing taun lumaku TARS|Wutah bathi resik saben saham ing taun iki cormedix.com CRMD|Seres Therapeutics, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku SPRO (Spero Therapeutics Inc)|Scynexis - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki AN2 Therapeutics, Inc. ANTX|polypid.com (PYPD) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku ysbiopharm.com (LSB)|Wutah bathi saben saham ing taun lumaku Iterum Therapeutics PLC|Wutah bathi saben saham ing taun iki PHGE (BiomX Ltd)|Wutah bathi saben saham ing taun lumaku Soligenix, Inc. (SNGX)|Prakiraan wutah bathi resik saben saham ing taun iki 60degreespharma.com|Wutah bathi saben saham ing taun lumaku Oragenics OGEN